Evaluation of131I-anti-angiotensin II type 1 receptor monoclonal antibody as a reporter for hepatocellular carcinoma

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Hao, Pan Pan ^a,b   Liu, Yan Ping ^a   Yang, Chang Ya ^a   Liang, Ting ^a   Zhang, Chao ^a   Song, Jing ^a   Han, Jian Kui ^b   Hou, Gui Hua ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; IMMUNOGLOBULIN G; IODINE 131;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY AFFINITY; ARTICLE; BINDING COMPETITION; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG HALF LIFE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; MEAN RESIDENCE TIME; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RADIATION DOSE DISTRIBUTION; RADIATION MEASUREMENT; RADIOACTIVITY; RADIOCHEMISTRY; RADIOIODINATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WHOLE BODY AUTORADIOGRAPHY;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; DRUG STABILITY; EARLY DIAGNOSIS; IMMUNOGLOBULIN G; IODINE RADIOISOTOPES; LIVER; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; RADIOPHARMACEUTICALS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 84896902973     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085002     Document Type: Article

References (28)

1. Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379: 1245-1255.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
3. Singal A, Volk ML, Waljee A, Salgia R, Higgins P, et al. (2009) Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther 30: 37-47.
4. Lok AS, Sterling RK, Everhart JE, Wright EC, Hoefs JC, et al. (2010) Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology 138: 493-502.
5. Colli A, Fraquelli M, Casazza G, Massironi S, Colucci A, et al. (2006) Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol 101: 513-523. (Pubitemid 43340927)
6. 131I-anti-MIF mAb as a reporter for allograft rejection. Clin Immunol 139: 40-47.
7. Dinh DT, Frauman AG, Sourial M, Casley DJ, Johnston CI, et al. (2001) Identification, distribution, and expression of angiotensin II receptors in the normal human prostate and benign prostatic hyperplasia. Endocrinology 14: 1349-1356. (Pubitemid 32202848)
8. Takeda H, Kondo S (2001) Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression. Am J Pathol 158: 1633-1637. (Pubitemid 32422928)
9. Kikkawa F, Mizuno M, Shibata K, Kajiyama H, Morita T (2004) Activation of invasiveness of cervical carcinoma cells by angiotensin II. Am J Obstet Gynecol 190: 1258-1263. (Pubitemid 38692206)
10. Suganuma T, Ino K, Shibata K, Kajiyama H, Nagasaka T (2005) Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination, Clin Cancer Res. 11: 2686-2694. (Pubitemid 40569470)
11. Won SM, Park YH, Kim HJ, Park KM, Lee WJ (2006) Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway. Exp Mol Med 38: 525-534.
12. Kosaka T, Miyajima A, Takayama E, Kikuchi E, Nakashima J, et al. (2007) Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer. Prostate 67: 41-49. (Pubitemid 46013466)
13. Zhang C, Hou G, Liang T, Song J, Qu L, et al. (2007) A prospective study of macrophage migration inhibitory factor as a marker of inflammatory detection. J Cell Mol Med 13: 4077-4083.
14. 99 mTc-labeled molecular probe for tumor angiogenesis imaging in hepatoma xenografts model: a pilot study. PLoS One 8: e61043.
15. Bonde MM, Hansen JT, Sanni SJ, Haunsø S, Gammeltoft S, et al. (2010) Biased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanisms. PLoS One 5: e14135.
16. Wu C, Wei J, Tian D, Feng Y, Miller RH, et al. (2008) Molecular Probes for Imaging Myelinated White Matter in CNS. J Med Chem 51: 6682-6688.
17. Jonathan S Wall, Stephen J Kennel, Angela Williams, Tina Richey, Alan Stuckey, et al. (2012) AL Amyloid Imaging and Therapy with a Monoclonal Antibody to a Cryptic Epitope on Amyloid Fibrils. PLoS One 7: e52686.
18. Ozeki K, Tanida S, Morimoto C, Inoue Y, Mizoshita T, et al. (2013) Telmisartan inhibits cell proliferation by blocking nuclear translocation of ProHB-EGF C-terminal fragment in colon cancer cells. PLoS One 8: e56770.
19. Khakoo AY, Sidman RL, Pasqualini R, Arap W (2008) Does the renin-angiotensin system participate in regulation of human vasculogenesis and angiogenesis? Cancer Res 68: 9112-9115.
20. Farazi PA, DePinho RA (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6: 674-687. (Pubitemid 44286000)
21. Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM (2007) Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 27: 55-76.
22. Heffelfinger SC (2007) The renin angiotensin system in the regulation of angiogenesis. Curr Pharm Des 13: 1215-1229.
23. Willis LM, El-Remessy AB, Somanath PR, Deremer DL, Fagan SC (2011) Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence. Clin Sci 120: 307-319.
24. Tahmasebi M, Barker S, Puddefoot JR, Vinson GP (2006) Localisation of reninangiotensin system (RAS) components in breast. Br J Cancer 95: 67-74. (Pubitemid 43980556)
25. Lau ST, Leung PS (2011) Role of the RAS in pancreatic cancer. Curr Cancer Drug Targets 11: 412-420.
26. Koh SL, Ager EI, Christophi C (2010) Liver regeneration and tumour stimulation: implications of the rennin-angiotensin system. Liver Int 30: 1414-1426.
27. Dzau VJ, Mukoyama M, Pratt RE (1994) Molecular biology of angiotensin receptors: target for drug research? J Hypertens Suppl 12: S1-S5. (Pubitemid 24212087)
28. Fujita M, Hayashi I, Yamashina S, Fukamizu A, Itoman M, et al. (2005) Angiotensin type 1a receptor signaling dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis 26: 271-279. (Pubitemid 40253497)